-transparent.png){kind=logo}
Pelvic lymphadenectomy as a staging procedure in clinically apparent prostatic adenocarcinoma has long been recognized and its value appreciated. Twenty-three recent cases from the University of Colorado of clinically unapparent carcinoma of the prostate were studied with this modality, 5 Stage A1 and 18 Stage A2 tumors. Four of the 18 Stage A2 tumors but none of the A1 lesions after negative staging procedures revealed metastatic disease to the pelvic lymph nodes. Our experience indicated this modality should be employed in selected cases of incidental adenocarcinoma of the prostate.
Related Publications
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
January 2009,
Urologiia (Moscow, Russia : 1999),
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
January 1982,
The Prostate,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
April 1982,
Urology,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
January 1995,
Annales d'urologie,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
January 1980,
The Journal of urology,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
May 1979,
The Journal of urology,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
August 1974,
The Journal of urology,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
October 1986,
Hinyokika kiyo. Acta urologica Japonica,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
January 1979,
Missouri medicine,
R E Donohue, and
R R Pfister, and
J W Weigel, and
O G Stonington
March 1980,
Military medicine,
